[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2019 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- 21.45%
YoY- 34.16%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 576,462 584,942 591,704 601,544 498,722 510,784 514,500 7.85%
PBT 70,809 75,826 74,204 75,144 59,666 56,010 52,340 22.25%
Tax -15,536 -18,173 -17,442 -17,284 -12,025 -11,648 -10,368 30.85%
NP 55,273 57,653 56,762 57,860 47,641 44,362 41,972 20.08%
-
NP to SH 55,273 57,653 56,762 57,860 47,641 44,362 41,972 20.08%
-
Tax Rate 21.94% 23.97% 23.51% 23.00% 20.15% 20.80% 19.81% -
Total Cost 521,189 527,289 534,942 543,684 451,081 466,421 472,528 6.73%
-
Net Worth 525,364 505,919 503,029 496,410 483,173 501,487 209,983 83.98%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 40,937 8,994 13,237 - 36,403 13,197 8,399 186.64%
Div Payout % 74.06% 15.60% 23.32% - 76.41% 29.75% 20.01% -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 525,364 505,919 503,029 496,410 483,173 501,487 209,983 83.98%
NOSH 684,383 680,106 661,881 661,881 661,881 661,881 650,902 3.39%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 9.59% 9.86% 9.59% 9.62% 9.55% 8.69% 8.16% -
ROE 10.52% 11.40% 11.28% 11.66% 9.86% 8.85% 19.99% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 84.49 86.71 89.40 90.88 75.35 77.41 183.76 -40.34%
EPS 8.25 8.65 8.52 8.76 7.26 6.79 6.44 17.90%
DPS 6.00 1.33 2.00 0.00 5.50 2.00 3.00 58.53%
NAPS 0.77 0.75 0.76 0.75 0.73 0.76 0.75 1.76%
Adjusted Per Share Value based on latest NOSH - 661,881
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 59.93 60.81 61.51 62.53 51.85 53.10 53.49 7.85%
EPS 5.75 5.99 5.90 6.01 4.95 4.61 4.36 20.19%
DPS 4.26 0.93 1.38 0.00 3.78 1.37 0.87 187.52%
NAPS 0.5461 0.5259 0.5229 0.5161 0.5023 0.5213 0.2183 83.97%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 1.42 1.40 1.37 1.28 0.95 1.23 1.30 -
P/RPS 1.68 1.61 1.53 1.41 1.26 1.59 0.71 77.29%
P/EPS 17.53 16.38 15.98 14.64 13.20 18.30 8.67 59.69%
EY 5.70 6.10 6.26 6.83 7.58 5.47 11.53 -37.39%
DY 4.23 0.95 1.46 0.00 5.79 1.63 2.31 49.51%
P/NAPS 1.84 1.87 1.80 1.71 1.30 1.62 1.73 4.18%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 -
Price 1.64 1.39 1.41 1.36 1.03 1.07 1.08 -
P/RPS 1.94 1.60 1.58 1.50 1.37 1.38 0.59 120.64%
P/EPS 20.24 16.26 16.44 15.56 14.31 15.92 7.20 98.80%
EY 4.94 6.15 6.08 6.43 6.99 6.28 13.88 -49.68%
DY 3.66 0.96 1.42 0.00 5.34 1.87 2.78 20.06%
P/NAPS 2.13 1.85 1.86 1.81 1.41 1.41 1.44 29.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment